The Food and Drug Administration approved the first generic version from a rival company of Mylan’s EpiPen injector device for life-threatening allergic reactions
WSJ.com: What's News US, Wall Street Journal
Thu, 08/16/2018 - 11:00am
The Food and Drug Administration approved the first generic version from a rival company of Mylan’s EpiPen injector device for life-threatening allergic reactions